These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8907924)

  • 21. Immunosuppressive effect of FK506 on orthotopic liver and small bowel xenotransplantation (xenoOLTx and SBTx).
    Zou XM; Yagihashi A; Tsuruma T; Matsuno T; Yamaguchi H; Asanuma K; Sasaki K; Hirata K
    Transplant Proc; 1996 Jun; 28(3):1437-9. PubMed ID: 8658729
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation.
    Fukuzawa M; Santiago S; Nakata S; Shirakura R; Okada A
    Transplant Proc; 1991 Dec; 23(6):3252-4. PubMed ID: 1721427
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats.
    Chen H; Xu D; Qi S; Busque S; Tan A; Daloze P
    Transplant Proc; 1997; 29(1-2):697-8. PubMed ID: 9123486
    [No Abstract]   [Full Text] [Related]  

  • 24. Indefinite small bowel allograft survival after limited immunosuppressive therapy is not due to specific hyporesponsiveness.
    Langrehr JM; Hoffman RA; Müller AR; Lee KK; Demetris AJ; Schraut WH
    Transplant Proc; 1991 Dec; 23(6):3248-50. PubMed ID: 1721425
    [No Abstract]   [Full Text] [Related]  

  • 25. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse.
    Chen H; Qi S; Xu D; Fitzsimmons WE; Bekersky I; Sehgal SN; Daloze P
    Transplant Proc; 1998 Sep; 30(6):2579-81. PubMed ID: 9745497
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation.
    Ye Q; Demetris AJ; Galvao FH; Toyama Y; Doughton CS; Todo S; Starzl TE; Murase N
    Transplant Proc; 1996 Oct; 28(5):2453. PubMed ID: 8907895
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged small bowel allograft survival following repeated intrathymic injections of donor splenocytes and peripheral anti-lymphocyte treatment.
    Sun S; Greenstein SM; Schechner RS; Tellis VA
    Transplant Proc; 1999; 31(1-2):588-9. PubMed ID: 10083249
    [No Abstract]   [Full Text] [Related]  

  • 29. A second intrathymic injection of donor splenocytes improves survival of small bowel allografts.
    Sun S; Greenstein SM; Kim DY; Schreiber TC; Schechner RS; Tellis VA
    Transplant Proc; 1998 Sep; 30(6):2575-6. PubMed ID: 9745495
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes of allo-intestinal graft survival and intragraft cytokine expression by bone marrow augmentation with tacrolimus treatment in rats.
    Nakao A; Sun DS; Inagaki M; Sadamori Y; Yagi T; Tanaka N
    Transplant Proc; 2001; 33(1-2):340-1. PubMed ID: 11266851
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of deoxyspergualin-induced host resistance to graft-versus-host reaction induced with small bowel transplantation in rats.
    Okitsu T; Tanaka S; Orita K
    Transplant Proc; 1995 Apr; 27(2):1609-11. PubMed ID: 7725422
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytokine mRNA expression on rat small bowel allograft treated with tacrolimus and simultaneous bone marrow transplantation via the portal vein.
    Nakao A; Yagi T; Sun DS; Matsukawa H; Endo A; Okada Y; Sadamori H; Inagaki M; Matsuno T; Tanaka N
    Transplant Proc; 2000 Sep; 32(6):1318-9. PubMed ID: 10995965
    [No Abstract]   [Full Text] [Related]  

  • 34. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 35. FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse.
    Chen H; Qi S; Xu D; Vu DM; Fitzsimmons WE; Bekersky I; Peets J; Sehgal SN; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1039-41. PubMed ID: 9636419
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 37. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosuppression in auxiliary partial liver transplantation with FK506 in rats.
    Hossain MA; Hamamoto I; Kobayashi S; Maeba T; Maeta H
    Transplant Proc; 1997 Dec; 29(8):3617-8. PubMed ID: 9414861
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation.
    Lee KK; Stangl MJ; Todo S; Langrehr JM; Hoffman A; Starzl TE; Schraut WH
    Transplant Proc; 1990 Dec; 22(6):2485-6. PubMed ID: 1702239
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolongation of survival of small bowel transplant recipients after treatment with cis-urocanic acid.
    Gieseler RK; Klemp F; Bredt M; Mentlein R; Kuhn R; von Gaudecker B; Peters JH; Schlemminger R
    Transplant Proc; 1994 Jun; 26(3):1601-3. PubMed ID: 8030054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.